Antonella Adami

Antonella Adami is a dedicated researcher at King's College London's School of Cancer and Pharmaceutical Sciences, Department of Immunobiology. With 80 citations to her name, she focuses on cutting-edge immunotherapy research, particularly in cancer treatment applications.

Her research interests span immunotherapy, cancer research, T cell biology, chimeric antigen receptor therapy, adoptive cell transfer, cytokine signaling, and malignant neoplasm research. Adami's work contributes significantly to UN Sustainable Development Goals related to health and well-being.

Adami's recent publications demonstrate a strong focus on CAR-T cell therapy development and optimization, with particular attention to overcoming challenges in solid tumor treatment. Her research examines innovative approaches including pan-ErbB targeting, IL-4-driven expansion techniques, and TGF-β1 potentiation of gamma delta T cells.

Her collaborative work spans multiple institutions and countries, reflecting the international nature of modern cancer immunotherapy research. While specific awards aren't documented in the available information, her 5 research outputs (including 4 articles and 1 review article) with substantial citation counts indicate recognition within her field.

Adami works closely with Professor John Maher and other collaborators across various research projects focused on advancing cellular immunotherapies for cancer treatment, with particular emphasis on translating laboratory findings into clinical applications.